Reference page — cumulative record through Wednesday, August 19, 2026 UTC. Reference pages update as the archive grows; only dated daily editions are immutable pages of record.
Product reference — CHARX SEC-3000 by Phoenix Contact · sector: Other. Cumulative disclosure record for this product across the archive.
Follow CHARX SEC-3000 — Atom feed
| All-time | YTD | |
|---|---|---|
| CVEs | 21 | 21 |
| KEV entries | 0 | 0 |
| KEV/100 | Med CVSS | Med EPSS | C | H | M | L |
|---|---|---|---|---|---|---|
| 0.0 | 8.5 | .0026 | 5 | 12 | 4 | 0 |
KEV/100 = KEV entries ÷ CVEs × 100. Med CVSS / Med EPSS are medians over this product's disclosures. C/H/M/L = disclosures by CVSS severity band.
Trend (by first-seen month, full archive): ▁█▁
| Month | New CVEs |
|---|---|
| 2026-06 | 1 |
| 2026-07 | 20 |
| 2026-08 | 0 |
Ranked by the published formula: KEV → EPSS → CVSS → CVE ID.
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-44098 | 8.8 | 69.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44108 | 9.3 | 38.4 | CRITICAL | — | 2026-07-30 |
| CVE-2026-7849 | 9.3 | 35.2 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44090 | 9.3 | 33.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44101 | 9.3 | 33.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44092 | 8.8 | 31.3 | HIGH | — | 2026-07-30 |
| CVE-2026-44091 | 8.8 | 25.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44107 | 8.7 | 23.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44100 | 8.8 | 20.2 | HIGH | — | 2026-07-30 |
| CVE-2026-41032 | 7.5 | 17.9 | HIGH | — | 2026-06-03 |
| CVE-2026-44094 | 8.3 | 17.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44097 | 5.3 | 15.9 | MEDIUM | — | 2026-07-30 |
| CVE-2026-44104 | 9.3 | 15.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44103 | 6.9 | 14.9 | MEDIUM | — | 2026-07-30 |
| CVE-2026-44093 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
| CVE | CVSS | EPSS %ile | Severity | KEV | First seen |
|---|---|---|---|---|---|
| CVE-2026-44096 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
| CVE-2026-44091 | 8.8 | 25.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44106 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
| CVE-2026-44101 | 9.3 | 33.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44105 | 5.8 | 0.7 | MEDIUM | — | 2026-07-30 |
| CVE-2026-44100 | 8.8 | 20.2 | HIGH | — | 2026-07-30 |
| CVE-2026-44095 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
| CVE-2026-44090 | 9.3 | 33.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44108 | 9.3 | 38.4 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44103 | 6.9 | 14.9 | MEDIUM | — | 2026-07-30 |
| CVE-2026-44098 | 8.8 | 69.7 | HIGH | — | 2026-07-30 |
| CVE-2026-44093 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
| CVE-2026-7849 | 9.3 | 35.2 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44104 | 9.3 | 15.5 | CRITICAL | — | 2026-07-30 |
| CVE-2026-44099 | 8.5 | 14.3 | HIGH | — | 2026-07-30 |
No entries in the CISA KEV catalog.
Vendor: Phoenix Contact — all products and the full vendor record.
A product is a (vendor, product) pair as named in the affected-product data. Rate statistics are arithmetic over published figures. Counts key to first-seen day. Raw counts are not comparable across products; this is a reference page assembled from the public record, not a ranking by our judgment.
Sources. CVE Program (cvelistV5), NVD (NIST), CISA KEV, FIRST EPSS.